“I have a theory that burnout is about resentment. And you beat it by knowing what it is you’re giving up that makes you resentful.”– Marissa Mayer
Laser intrastromal astigmatic keratotomy yields stable correction up to 6 months
Femtosecond laser-assisted cataract surgery with or without intrastromal astigmatic keratotomy yielded small but statistically significant regressions in surgically induced astigmatism, according to a study.One of the potential advantages of femtosecon…
Minimally invasive micro sclerostomy may be alternative to trabeculectomy
The gold standard surgery for decreasing IOP in patients with glaucoma is trabeculectomy. However, it has possible disadvantages, such as failure secondary to subconjunctival fibrosis and postoperative bleb-related ocular inflammation. This has led sur…
Keys for a successful practice include implementing, establishing brand recognition
Practicing ophthalmology during this era of comprehensive health care reform and constantly evolving technology requires a level of diligence never before required of physicians. With the substantial energy and work expended in keeping up with the latest equipment, techniques and regulations, it is easy to overlook a key component of managing a successful business: branding and marketing a practice.On the heels of the 2007 “boom” period for LASIK, when roughly 1.4 million procedures were performed annually in the U.S., we were confronted with the economic recession spanning from 2008 to 2012, when the number of LASIK procedures dropped by half. As expected, many of us experienced a decline in our refractive and elective ophthalmologic procedures. Although current economic indicators are ticking up, the number of LASIK procedures seems to have plateaued at about 650,000 annually.
VIDEO: OCT-angiography proving useful in uveitic diagnoses
SEATTLE — At the Association for Research in Vision and Ophthalmology meeting, Damien Rodger, MD, of the USC Roski Eye Institute, discusses the utility of OCT-angiography in diagnosing and tracking uveitis.
VIDEO: Luminate meets primary endpoint in phase 2 study for vitreomacular traction
SEATTLE — At the Association for Research in Vision and Ophthalmology meeting, Baruch D. Kuppermann, MD, discusses results of the phase 2 study of Allegro’s Luminate for the treatment of vitreomacular traction.